ArticleWorld journal of gastrointestinal oncology2019

ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma.

Hiroaki Takaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.